New drug treatment Kyprolis (carfilzomib) for relapsed multiple myeloma launches in the UK

Amgen has announced that Kyprolis® (carfilzomib) in combination with lenalidomide and dexamethasone is now available in the UK for the treatment of adult patients with multiple myeloma who have… Source link